121 results
Page 2 of 7
8-K
EX-99.1
8ajhya1tdzmc 8z
15 Nov 23
Other Events
5:14pm
8-K
EX-99.2
1qh92td ob3e0te
15 Nov 23
Other Events
5:14pm
8-K
EX-99.1
o2ru5k200hdy
9 Nov 23
Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
CORRESP
7t4sj6f5zk5fu7iecab8
26 Oct 23
Correspondence with SEC
12:00am
8-K
EX-99.1
lq5zgv9
24 Oct 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
7i71rjskdi3ue
10 Oct 23
Report of Independent Registered Public Accounting Firm
12:00am
PRER14A
uzeh j13z93jh
6 Oct 23
Preliminary revised proxy
9:40pm
8-K
EX-99.1
65u16c9sgqy72
8 Sep 23
Material Modifications to Rights of Security Holders
5:05pm
CORRESP
up7iingalkki2bn
8 Sep 23
Correspondence with SEC
12:00am
8-K
EX-99.1
5xw5fgg 27piq7ng24
11 Aug 23
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
7:02am
8-K
EX-99.1
9wkmq
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-2.1
ha4ieyruedjegsxp1r
23 Jun 23
Entry into a Material Definitive Agreement
9:16am